RENOVORX, INC. Selling, General and Administrative Expense
RENOVORX, INC. (RNXT) reported Selling, General and Administrative Expense of $2.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-13
- RENOVORX, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.92M, a 91.52% increase year-over-year.
- RENOVORX, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.72M, a 73.14% increase year-over-year.
- RENOVORX, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $2.23M, a 103.00% increase year-over-year.
- RENOVORX, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.73M, a 46.69% increase year-over-year.
- RENOVORX, INC. selling, general and administrative expense for fiscal 2025 was $7.04M, a 41.08% increase from fiscal 2024.
- RENOVORX, INC. selling, general and administrative expense for fiscal 2024 was $4.99M, a 12.93% decline from fiscal 2023.
- RENOVORX, INC. selling, general and administrative expense for fiscal 2023 was $5.73M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.92M 10-Q · filed 2026-08-13 | $5.63M 10-Q · filed 2026-08-13 | $7.87M derived: sum of 3 quarters · filed 2026-08-13 | $9.59M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.72M 10-Q · filed 2026-05-14 | $4.95M derived: sum of 2 quarters · filed 2026-05-14 | $6.68M derived: sum of 3 quarters · filed 2026-05-14 | $8.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.96M derived: sum of 2 quarters · filed 2026-03-30 | $5.48M derived: sum of 3 quarters · filed 2026-08-13 | $7.04M 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.73M 10-Q · filed 2025-11-13 | $3.25M derived: sum of 2 quarters · filed 2026-08-13 | $4.81M 10-Q · filed 2025-11-13 | $5.92M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.52M 10-Q · filed 2026-08-13 | $3.09M 10-Q · filed 2026-08-13 | $4.19M derived: sum of 3 quarters · filed 2026-08-13 | $5.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.57M 10-Q · filed 2026-05-14 | $2.67M derived: sum of 2 quarters · filed 2026-05-14 | $3.85M derived: sum of 3 quarters · filed 2026-05-14 | $5.34M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.28M derived: sum of 2 quarters · filed 2026-03-30 | $3.77M derived: sum of 3 quarters · filed 2026-03-30 | $4.99M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.18M 10-Q · filed 2025-11-13 | $2.67M derived: sum of 2 quarters · filed 2025-11-13 | $3.89M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.49M 10-Q · filed 2025-08-14 | $2.71M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $5.73M 10-K · filed 2025-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |